Clinical Trial Update: A Study of HS-10353 in Adult Participants With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HS-10353 in adults with Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• HS-10353

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: UNKNOWN